Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS -altered, younger patients with colorectal cancer
The Oncologist · 2024
DOI: 10.1093/oncolo/oyae153 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Madappa N Kundranda und 8 weiteren Autor:innen. Beteiligte Einrichtung: Banner MD Anderson Cancer Center, Gilbert, AZ, United States. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Biomarkers, Tumor, Microsatellite Instability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Exact Sciences Corporation.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a common cancer in younger adults. In patients undergoing liver resection with RAS-altered CRCs, there is evidence suggesting younger patients have worse outcomes than older patients. To explain this pattern, differences in associations between RAS status and other cancer-related biomarkers in tumors from younger versus older patients with CRC were evaluated in a cohort of 925 patients with CRC, 277 (30.0%) of whom were ≤50 years old, and 454 (49.1%) who had RAS-altered tumors. For 3 biomarkers, RNF43, APC, and microsatellite instability (MSI), the association with RAS status was significantly modified by age after adjustment for multiple testing. Specifically, younger patients with RAS-altered tumors were more likely to be MSI-high, RNF43 mutated, and APC wild type. These differences might contribute to the observed pattern of diminished survival in younger versus older patients with CRC with RAS-mutated tumors undergoing liver metastasis resection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Banner MD Anderson Cancer Center, Gilbert, AZ, United States.
- Exact Sciences Corporation, Madison, WI, United States.
ORCID-Profile: David W Hall
Förderung
- Exact Sciences Corporation
Zitieren
APA
Kundranda, M. N., Kemkes, A. C., Evans, M. C., Flannery, C. A., Hall, D. W., Hoag, J. R., Therala, N., Thakkar, S. G., & De La O, J. P. (2024). Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS -altered, younger patients with colorectal cancer. The Oncologist. https://doi.org/10.1093/oncolo/oyae153
Vancouver
Kundranda MN, Kemkes AC, Evans MC, Flannery CA, Hall DW, Hoag JR, et al. Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS -altered, younger patients with colorectal cancer. The Oncologist. 2024. doi:10.1093/oncolo/oyae153
BibTeX
@article{Kundranda2024,
author = {Kundranda, Madappa N and Kemkes, Ariane C and Evans, Mark C and Flannery, Cynthia A and Hall, David W and Hoag, Jess R and Therala, Nishitha and Thakkar, Snehal G and De La O, Jean-Paul},
title = {Associations with other cancer-related biomarkers might contribute to poor outcomes in RAS -altered, younger patients with colorectal cancer},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyae153}
}
EUVIMED